First Trust Nasdaq Pharmaceuticals ETF (FTXH) is a publicly traded company in the Financial Services sector, operating within the Asset Management industry.
FTXH has IPO date of 2016-09-22, listed on the NASDAQ Global Market, a market capitalization of $29.29M.
The First Trust Nasdaq Pharmaceuticals ETF is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield, before the Fund's fees and expenses, of an index called the Nasdaq US Smart Pharmaceuticals Index. The Fund seeks to replicate the holdings and weightings of the Nasdaq US Smart Pharmaceuticals Index so as to generate performance results 95% correlated to that of the Nasdaq US Smart Pharmaceuticals Index.
